AtaiBeckley (ATAI) Depreciation & Amortization (CF) (2020 - 2026)

AtaiBeckley's (ATAI) quarterly Depreciation & Amortization (CF) came in at $233000.0 in Q3 2025, up 180.72% year-on-year from $83000.0 in Q3 2024, and up 2.64% quarter-over-quarter from $227000.0 in Q2 2025.

AtaiBeckley (ATAI) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

AtaiBeckley's Depreciation & Amortization (CF) history runs 2 years deep, the most recent figure standing at $167000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 22.69% year-over-year to $167000.0; the TTM figure through Mar 2026 stood at $383000.0 (changed N/A YoY), while the FY2025 annual figure was $1.0 million, up 113.95% from the prior year.
  • Depreciation & Amortization (CF) came in at $233000.0 for Q3 2025 at AtaiBeckley, up from $227000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $216000.0 in Q1 2025 to a low of $167000.0 in Q1 2026.
  • The 5-year median for Depreciation & Amortization (CF) is $74000.0 (2023), against an average of $88578.9.
  • Across the five-year window, Depreciation & Amortization (CF) plunged 240.0% in 2021 and surged 900.0% in 2022, its largest moves.
  • AtaiBeckley's Depreciation & Amortization (CF) stood at $29000.0 in 2021, then soared by 82.76% to $53000.0 in 2022, then soared by 90.57% to $101000.0 in 2023, then surged by 122.77% to $225000.0 in 2024, then advanced by 3.56% to $233000.0 in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $233000.0 (Q3 2025), $227000.0 (Q2 2025), and $216000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 AtaiBeckley 1.45 Bn 1.45 Bn - 167,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 167,000.00
Mar 31, 2026 167,000.00
Sep 30, 2025 233,000.00
Sep 30, 2025 233,000.00
Jun 30, 2025 227,000.00
Jun 30, 2025 227,000.00
Mar 31, 2025 216,000.00
Mar 31, 2025 216,000.00
Mar 31, 2025 216,000.00
Mar 31, 2025 216,000.00
Dec 31, 2024 225,000.00
Dec 31, 2024 225,000.00
Sep 30, 2024 83,000.00
Sep 30, 2024 83,000.00
Jun 30, 2024 82,000.00
Jun 30, 2024 82,000.00
Mar 31, 2024 83,000.00
Mar 31, 2024 83,000.00
Dec 31, 2023 101,000.00
Dec 31, 2023 101,000.00